Entrectinib
Quiénes somos
Protocolo de redescubrimiento de fármacos (ensayo DRUP)
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Estudio de la plataforma TAPISTRY (Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
